Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cerebrovascular disease in mild cognitive impairment subtypes

Archives of Neurology

Volumn 65, Issue 12, 2008, Pages 1621-1628

  Kantarci, Kejal ^a   Petersen, Ronald C ^a   Przybelski, Scott A ^a   Weigand, Stephen D ^a   Shiung, Maria M ^a   Whitwell, Jennifer L ^a   Negash, Selamawit ^a   Ivnik, Robert J ^a   Boeve, Bradley F ^a   Knopman, David S ^a   Smith, Glenn E ^a   Jack Jr , Clifford R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN INFARCTION; BRAIN SIZE; CASE CONTROL STUDY; CEREBROVASCULAR DISEASE; CINGULATE GYRUS; COGNITIVE DEFECT; DEGENERATIVE DISEASE; FEMALE; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLITE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TERTIARY HEALTH CARE;

AGED; AGED, 80 AND OVER; ASPARTIC ACID; CASE-CONTROL STUDIES; CEREBROVASCULAR DISORDERS; CHI-SQUARE DISTRIBUTION; CHOLINE; COGNITION DISORDERS; COHORT STUDIES; CREATINE; FEMALE; HIPPOCAMPUS; HUMANS; LIKELIHOOD FUNCTIONS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEUROPSYCHOLOGICAL TESTS; PROTONS;

EID: 61449238161     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.65.12.1621     Document Type: Article

References (59)

1. Petersen RC. Mild cognitive impairment. Continuum. 2004;10(1):9-28.
2. Fischer P, Jungwirth S, Zehetmayer S, et al. Conversion from subtypes of mild cognitive impairment to Alzheimer dementia. Neurology. 2007;68(4):288-291.
3. Flicker C, Ferris SH, Reisberg B. Mild cognitive impairment in the elderly: predictors of dementia. Neurology. 1991;41(7):1006-1009.
4. Morris JC, Storandt M, Miller JP, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol. 2001;58(3):397-405.
5. Busse A, Hensel A, Guhne U, Angermeyer MC, Riedel-Heller SG. Mild cognitive impairment: long-term course of four clinical subtypes. Neurology. 2006;67(12):2176-2185.
6. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56(9):1133-1142.
7. Bowen J, Teri L, Kukull W, McCormick W, McCurry SM, Larson EB. Progression to dementia in patients with isolated memory loss. Lancet. 1997;349(9054):763-765.
8. Yaffe K, Petersen RC, Lindquist K, Kramer J, Miller B. Subtype of mild cognitive impairment and progression to dementia and death. Dement Geriatr Cogn Disord. 2006;22(4):312-319.
9. Bennett DA, Wilson RS, Schneider JA, et al. Natural history of mild cognitive impairment in older persons. Neurology. 2002;59(2):198-205.
10. Storandt M, Grant EA, Miller JP, Morris JC. Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI. Neurology. 2006;67(3):467-473.
11. Petersen RC, Parisi JE, Dickson DW, et al. Neuropathologic features of amnestic mild cognitive impairment. Arch Neurol. 2006;63(5):665-672.
12. Jicha GA, Parisi JE, Dickson DW, et al. Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia. Arch Neurol. 2006;63(5):674-681.
13. Morris JC, Price AL. Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J Mol Neurosci. 2001;17(2):101-118.
14. Barkhof F, Polvikoski TM, van Straaten EC, et al. The significance of medial temporal lobe atrophy: a postmortem MRI study in the very old. Neurology. 2007;69(15):1521-1527.
15. Bobinski M, Wegiel J, Tarnawski M, et al. Relationships between regional neuronal loss and neurofibrillary changes in the hippocampal formation and duration and severity of Alzheimer disease. J Neuropathol Exp Neurol. 1997;56(4):414-420.
16. Gosche KM, Mortimer JA, Smith CD, Markesbery WR, Snowdon DA. Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study. Neurology. 2002;58(10):1476-1482.
17. Jack CR Jr, Dickson DW, Parisi JE, et al. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology. 2002;58(5):750-757.
18. Jagust WJ, Zheng L, Harvey DJ, et al. Neuropathological basis of magnetic resonance images in aging and dementia. Ann Neurol. 2008;63(1):72-80.
19. Zarow C, Vinters HV, Ellis WG, et al. Correlates of hippocampal neuron number in Alzheimer's disease and ischemic vascular dementia. Ann Neurol. 2005;57(6):896-903.
20. 1H MR spectroscopy metabolite measurements. Radiology. 2008;248(1):210-220.
21. 1H MR spectroscopy in common dementias. Neurology. 2004;63(8):1393-1398.
22. Metastasio A, Rinaldi P, Tarducci R, et al. Conversion of MCI to dementia: role of proton magnetic resonance spectroscopy. Neurobiol Aging. 2006;27(7):926-932.
23. Shonk TK, Moats RA, Gifford P, et al. Probable Alzheimer disease: diagnosis with proton MR spectroscopy. Radiology. 1995;195(1):65-72.
24. Jessen F, Block W, Traber F, et al. Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD. Neurology. 2000;55(5):684-688.
25. Chao LL, Schuff N, Kramer JH, et al. Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patients. Neurology. 2005;64(2):282-289.
26. 1H MRS study. Neurology. 2000;55(2):210-217.
27. Schuff N, Capizzano AA, Du AT, et al. Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD. Neurology. 2002;58(6):928-935.
28. 1H magnetic resonance spectroscopic metabolic pattern in the medial temporal lobes of patients with mild cognitive impairment and Alzheimer disease. Brain Res. 2004;1003(1-2):26-35.
29. Whitwell JL, Petersen RC, Negash S, et al. Patterns of atrophy differ among specific subtypes of mild cognitive impairment. Arch Neurol. 2007;64(8):1130-1138.
30. Bombois S, Debette S, Delbeuck X, et al. Prevalence of subcortical vascular lesions and association with executive function in mild cognitive impairment subtypes. Stroke. 2007;38(9):2595-2597.
31. Yoshita M, Fletcher E, Harvey D, et al. Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD. Neurology. 2006;67(12):2192-2198.
32. Zanetti M, Ballabio C, Abbate C, Cutaia C, Vergani C, Bergamaschini L. Mild cognitive impairment subtypes and vascular dementia in community-dwelling elderly people: a 3-year follow-up study. J Am Geriatr Soc. 2006;54(4):580-586.
33. Mariani E, Monastero R, Ercolani S, et al; ReGAl Study Group. Vascular risk factors in mild cognitive impairment subtypes: findings from the ReGAl Project. Dement Geriatr Cogn Disord. 2007;24(6):448-456.
34. Petersen RC, Kokmen E, Tangalos E, Ivnik RJ, Kurland LT. Mayo Clinic Alzheimer's Disease Patient Registry. Aging (Milano). 1990;2(4):408-415.
35. Rey A. L'examen clinique en psychologie. Paris: Universitaires de France; 1964.
36. Kaplan E, Goodglass H, Weintraub S. The Boston Naming Test. 2nd ed. Philadelphia, PA: Lea & Febiger; 1983.
37. Lucas JA, Ivnik RJ, Smith GE, et al. Mayo's Older Americans Normative Studies: category fluency norms. J Clin Exp Neuropsychol. 1998;20(2):194-200.
38. Spreen O, Strauss E. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. New York, NY: Oxford University Press; 1998.
39. Ivnik RJ, Malec JF, Smith GE, Tangalos EG, Petersen RC. Neuropsychological tests' norms above age 55: COWAT, BNT, MAE Token, WRAT-R Reading, AMNART, STROOP, TMT, and JLO. Clin Neuropsychol. 1996;10(3):262-278.
40. Ivnik RJ, Malec JF, Smith GE, et al. Mayo's Older Americans Normative Studies: WAIS-R, WMS-R and AVLT norms for ages 56 through 97. Clin Neuropsychol. 1992;6(suppl 1):1-104.
41. Jack CR Jr, Bentley MD, Twomey CK, Zinsmeister AR. MR imaging-based volume measurements of the hippocampal formation and anterior temporal lobe: validation studies. Radiology. 1990;176(1):205-209.
42. Jack CR Jr, Petersen RC, Xu YC, et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology. 1997;49(3):786-794.
43. Jack CR Jr, O'Brien PC, Rettman DW, et al. FLAIR histogram segmentation for measurement of leukoaraiosis volume. J Magn Reson Imaging. 2001;14(6):668-676.
44. Wu CC, Mungas D, Petkov CI, et al. Brain structure and cognition in a community sample of elderly Latinos. Neurology. 2002;59(3):383-391.
45. Murray ME, Shiung MM, Weigand SD, et al. Mayo MRI visual grading scale: validation studies. Presented at: Annual Meeting of the Society for Neuroscience; November 5, 2007; San Diego, CA.
46. Webb PG, Sailasuta N, Kohler SJ, Raidy T, Moats RA, Hurd RE. Automated single-voxel proton MRS: technical development and multisite verification. Magn Reson Med. 1994;31(4):365-373.
47. Agresti A. Categorical Data Analysis. 2nd ed. Hoboken, NJ: John Wiley & Sons Inc; 2002.
48. O'Brien PC. The appropriateness of analysis of variance and multiple-comparison procedures. Biometrics. 1983;39(3):787-794.
49. Perneger TV. What's wrong with Bonferroni adjustments. BMJ. 1998;316(7139):1236-1238.
50. Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007;69(24):2197-2204.
51. Josephs KA, Whitwell JL, Duffy JR, et al. Progressive aphasia secondary to Alzheimer disease vs FTLD pathology. Neurology. 2008;70(1):25-34.
52. Murray ME, Dickson DW. Alzheimer's disease with relative hippocampal sparing: a distinct clinicopathological variant [abstract]. Alzheimers Dement. 2008;4(4)(suppl 2):T106.
53. Zimmerman ME, Pan JW, Hetherington HP, et al. Hippocampal neurochemistry, neuromorphometry, and verbal memory in nondemented olderadults. Neurology. 2008;70(18):1594-1600.
54. DeCarli C, Mungas D, Harvey D, et al. Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia. Neurology. 2004;63(2):220-227.
55. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348(13):1215-1222.
56. DeCarli C, Miller BL, Swan GE, Reed T, Wolf PA, Carmelli D. Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Arch Neurol. 2001;58(4):643-647.
57. Luchsinger J, Brickman A, Reitz C, et al. Cerebrovascular disease in mild cognitive impairment [abstract]. Alzheimers Dement. 2008;4(4)(suppl 2):T131.
58. Bennett DA, Schneider JA, Bienias JL, Evans DA, Wilson RS. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology. 2005;64(5):834-841.
59. Whitwell JL, Weigand SD, Shiung MM, et al. Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease. Brain. 2007;130(pt 3):708-719.